Teva Pharmaceutical Industries (NYSE:TEVA), a global leader in generic and specialty medicines with a market capitalization of $24.93 billion, has been navigating a complex market landscape with a mix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback